Related Experiment Videos
[Arteriosclerosis and coronary heart disease--strengths and weaknesses in the classical risk factor concept]
1Zentrum Innere Medizin, Schwerpunkt Kardiologie, Philipps-Universität Marburg. schaefe5@mailer.uni-marburg.de
Insights
Cardiovascular disease (CVD) risk factors like high LDL-cholesterol are well-known. Further research is needed to identify additional CVD risk factors for better prevention, as current treatments are insufficient for many patients.
Area of Science:
- Cardiology
- Biochemistry
- Preventive Medicine
Context:
- Hypercholesterolemia is a significant cardiovascular risk factor.
- Cholesterol-lowering therapies show benefits in primary and secondary prevention.
- Many coronary artery disease (CAD) patients experience recurrent events despite treatment.
Purpose:
- To highlight the limitations of current understanding of cardiovascular risk factors.
- To emphasize the need for identifying additional CAD risk factors.
- To underscore the inadequacy of existing lipid-lowering treatments for preventing recurrent events.
Summary:
- Several cardiovascular risk factors, including high LDL-cholesterol, low HDL-cholesterol, homocystein, and Lp(a), have been identified.
- Despite the known importance of hypercholesterolemia and the efficacy of lipid-lowering therapies, many CAD patients face recurrent events.
- Moderate hypercholesterolemia has limited predictive power for myocardial infarction, necessitating further investigation.
Impact:
- Identifies gaps in current cardiovascular disease prevention strategies.
- Highlights the need for novel risk factors beyond traditional lipid profiles.
- Emphasizes the importance of continued research in CAD prevention to improve patient outcomes.
Abstract:
Several cardiovascular risk factors were identified (high LDL-cholesterol, low HDL-cholesterol, homocystein, Lp(a), and many others). Hypercholesterolemia has been shown to be one of the most important cardiovascular risk factors in man. Interventional studies for primary and secondary prevention demonstrate a beneficial effect of cholesterol lowering therapy. However, numerous CAD-patients suffer a second coronary event despite the appropriate lipid-lowering treatment. Furthermore moderate hypercholesterolemia has only poor predictive power indicating an upcoming myocardial infarction. Therefore we need additional research in CAD prevention and in identifying so far unknown or unconsidered CAD risk factors.